retatrutide peptide eli lilly stock jumps on Phase 3 weight loss results Retatrutide, an investigational triple hormone

Regular check-ins ensure dosing is optimized and well-tolerated

TruLaws legal team recognizes that these vision loss cases may command substantially higher settlement values due to the profound, permanent nature of blindness and the complete absence of any warnings about this risk on Ozempic labels before international regulatory action in 2025

For example, in a double-blind, placebo-controlled study of 49 subjects, those receiving 550 mg of Berbevis twice daily for two months showed significant improvements in blood lipids, blood sugar control, total fat mass (-6%), and abdominal (visceral) fat mass (-11%)

Market Growth and Pressure to Expand Access The GLP1 weight loss market in South Africa brought in around R989 million in 2024